PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
23612197-3	2013	In vitro, tedizolid and linezolid were reversible inhibitors of human MAO-A and MAO-B; the 50% inhibitory concentration (IC50) for tedizolid was 8.7 muM for MAO-A and 5.7 muM for MAO-B and 46.0 and 2.1 muM, respectively, with linezolid.	tedizolid	10-19	monoamine oxidase A	Homo sapiens	70-75	
23612197-3	2013	In vitro, tedizolid and linezolid were reversible inhibitors of human MAO-A and MAO-B; the 50% inhibitory concentration (IC50) for tedizolid was 8.7 muM for MAO-A and 5.7 muM for MAO-B and 46.0 and 2.1 muM, respectively, with linezolid.	tedizolid	10-19	monoamine oxidase A	Homo sapiens	157-168	
23612197-3	2013	In vitro, tedizolid and linezolid were reversible inhibitors of human MAO-A and MAO-B; the 50% inhibitory concentration (IC50) for tedizolid was 8.7 muM for MAO-A and 5.7 muM for MAO-B and 46.0 and 2.1 muM, respectively, with linezolid.	tedizolid	131-140	monoamine oxidase A	Homo sapiens	70-75	
23612197-3	2013	In vitro, tedizolid and linezolid were reversible inhibitors of human MAO-A and MAO-B; the 50% inhibitory concentration (IC50) for tedizolid was 8.7 muM for MAO-A and 5.7 muM for MAO-B and 46.0 and 2.1 muM, respectively, with linezolid.	tedizolid	131-140	monoamine oxidase A	Homo sapiens	157-168	
23612197-9	2013	In summary, tedizolid is a weak, reversible inhibitor of MAO-A and MAO-B in vitro.	tedizolid	12-21	monoamine oxidase A	Homo sapiens	57-62